Inventor
JARY HÉLÈNE MARIE
FR9 patents
⚠️ This page may combine multiple inventors who share the name “JARY HÉLÈNE MARIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GALAPAGOS NV
8 patentsUS9926281B2Mar 27, 2018
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
GALAPAGOS NV6 citations81
US10487060B2Nov 26, 2019
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
GALAPAGOS NV4 citations70
US11339166B2May 24, 2022
Compounds and pharmaceutical compositions thereof for the treatment of diseases
GALAPAGOS NV2 citations68
US11718588B2Aug 8, 2023
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
GALAPAGOS NV0 citations59
US10941117B2Mar 9, 2021
5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
GALAPAGOS NV0 citations59
US12065443B2Aug 20, 2024
Compounds and pharmaceutical compositions thereof for the treatment of diseases
GALAPAGOS NV0 citations58
US10829478B2Nov 10, 2020
5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritis
GALAPAGOS NV0 citations37
US10550100B2Feb 4, 2020
5-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritis
GALAPAGOS NV0 citations37